Showing results (1321-1330 of 3,182) with videos related to
Sort By:
Pageof 319
Translational Oncology|February 8, 2025
Malignant phyllodes tumors with sarcomatous components: A histopathologic and molecular studyTing Lei, Yunjie Song, Zhiyi Shen, et al.Translational Oncology|February 4, 2025
Comprehensive multi-omics analysis showed that CDC6 is a potential prognostic and immunotherapy biomarker for multiple cancer types including HCCChenxuan Li, En-di Zhang, Rui Yu, et al.Translational Oncology|February 5, 2025
Comparison of prognosis for T4b rectal cancer with different pelvic compartment involvement treated using neoadjuvant chemoradiotherapy and implications for refinement of the current T staging system: A retrospective cohort studyYang-Zi Zhang, Maxiaowei Song, Shuai Li, et al.Translational Oncology|January 28, 2025
TRIM29 reverses lenvatinib resistance in liver cancer cells by ubiquitinating and degrading YBX1 to inhibit the PI3K/AKT pathwayYuhong Tang, Songong Fan, Rui Peng, et al.Translational Oncology|January 28, 2025
LncRNA TCL6 regulates miR-876-5p/MYL2 axis to suppress breast cancer progressionYaoBang Liu, Hong Li, DaHai Chai, et al.Translational Oncology|January 26, 2025
HNF4α inhibits the malignancy of intrahepatic cholangiocarcinoma by suppressing the Wnt signaling pathwayBo-Nan Xu, Cheng-Hong Ding, Yi-Long Liu, et al.Translational Oncology|February 22, 2025
Thiostrepton suppresses intrahepatic cholangiocarcinoma progression via FOXM1-mediated tumor-associated macrophages reprogrammingYu Li, Yifan Jiang, Rongliang Tong, et al.Translational Oncology|February 27, 2025
Discovering the Potential Role of the C2 DUSP2+ MCs Subgroup in Lung AdenocarcinomaShengyi Zhang, Xinhan Li, Zhikai Xiahou, et al.Translational Oncology|January 14, 2025
Molecular profiling of bladder cancer xenografts defines relevant molecular subtypes and provides a resource for biomarker discoverySharada Mokkapati, Ganiraju Manyam, Alexis R Steinmetz, et al.Translational Oncology|January 3, 2025
Habitat radiomics based on CT images to predict survival and immune status in hepatocellular carcinoma, a multi-cohort validation studyKun Chen, Chunxiao Sui, Ziyang Wang, et al.Pageof 319